 | | Nevirapine (Viramune) |  | | Published
January 25, 2001; Updated
March 2013 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-02-01 | | | Selected Reference | | 17. | Clarke
SM, Mulcahy
FM, Tjia
J, Reynolds
HE, Gibbons
SE, Barry
MG, Back
DJ.
Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users. Clin Infect Dis. 2001 Nov;33(9):1595-7
[PubMed ID: 11568856]
| | | Abstract:
Administration of nevirapine to HIV-infected injection drug users who also receive methadone results in a significant reduction in methadone exposure after 7-10 days of therapy. Many patients require an increase in methadone dose to counteract this effect. | |
|
|
|
